Skip to main content

Table 1 Failed neonatal hearing screening: multivariate logistic regression of risk factors

From: Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants

  Failed neonatal hearing screening [% (n failed hearing screening/n with risk factor) OR 95% CI p
All 11% (788/7056) Ref.   
Birth weight#   0.91 0.88-0.94 7.3 × 10-10*
No Aminoglycosides, m.1555A>G - 8.5% (224/2636) 1.26 1.07-1.49 0.0058*
No Aminoglycosides m.1555A>G + 0% (0/2)
Aminoglycosides m.1555A>G - 12.7% (561/4408)
Aminoglycosides m.1555A>G + 30% (3/10)
Vancomycin treatment 15.8% (349/2208) 1.24 1.04-1.47 0.015
Furosemide treatment 17.6% (238/1355) 1.29 1.08-1.57 0.0066*
Cytomegalovirus-infection 27% (6/22) 1.80 0.69-4.7 0.23
Infants with BPD 18.6% (195/1048) 1.21 0.99-1.49 0.067
  1. #OR for birth weight is given per 100 g increased weight. Percentage of failed hearing screening for each category is given in Figure 1. *p < 0.007, multivariate logistic regression.